GB1060513A - Process for the preparation of glucuronoglycosaminoglycan hyaluronate lyase - Google Patents

Process for the preparation of glucuronoglycosaminoglycan hyaluronate lyase

Info

Publication number
GB1060513A
GB1060513A GB640465A GB640465A GB1060513A GB 1060513 A GB1060513 A GB 1060513A GB 640465 A GB640465 A GB 640465A GB 640465 A GB640465 A GB 640465A GB 1060513 A GB1060513 A GB 1060513A
Authority
GB
United Kingdom
Prior art keywords
precipitate
solution
treating
mls
adjusting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB640465A
Inventor
Lily Baxendale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biorex Laboratories Ltd
Original Assignee
Biorex Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Laboratories Ltd filed Critical Biorex Laboratories Ltd
Priority to GB640465A priority Critical patent/GB1060513A/en
Priority to ES0323078A priority patent/ES323078A1/en
Publication of GB1060513A publication Critical patent/GB1060513A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Hyaluronidase (glucuronoglycosaminoglycan hyaluronate lyase) is prepared from animal organs or products thereof containing the said enzyme, by: i) macerating with aqueous acetic acid containing 2.5 to 10% by volume hydrochloric acid, and centrifuging off the solids, ii) treating the supernatant with 21 g. ammonium sulphate per 200 mls. solution and removing the precipitate, iii) treating the resulting supernatant with 56.5 g. ammonium sulphate per 200 mls. solution, collecting the precipitate, and dissolving it in the minimum amount of water, iv) ultra-filtering this solution to 1/10 of its original volume, and dialysing the concentrae against water, v) treating the dialysate with two volumes of chloroform, separating the aqueous layer, centrifuging off any precipitate, and adjusting to pH 2.3, and standing for 1 to 15 minutes, then adjusting to pH 4.8, and removing the precipitate, vi) treating the clarified solution with 10 g. ammonium sulphate per 100 mls, and collecting the precipitae, vii) dissolving the precipitate in water and dialysing against physiological saline, viii) chromatographing the dialysate through a column of cross-linked sulphonated polystyrene ion exchange resin and eluting with pH 1.5 KCl/HCl buffer, ix) adjusting the pH of the elurate to 6.0 and ultra-filtering to 1/20 of its original volume and x) lyophilising the concentrated solution, if required. The product may be further purified by preparative electrophoresis on starch gel or polyacrylamide gel. Suitable starting materials are bulls' testicles or liver lysozymes. The product is said to have an activity of at least 21,500 International units and to be almost free from contaminating enzymes.
GB640465A 1965-02-15 1965-02-15 Process for the preparation of glucuronoglycosaminoglycan hyaluronate lyase Expired GB1060513A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB640465A GB1060513A (en) 1965-02-15 1965-02-15 Process for the preparation of glucuronoglycosaminoglycan hyaluronate lyase
ES0323078A ES323078A1 (en) 1965-02-15 1966-02-15 Procedure for the preparation of enzymes of glucuronoglicosaminoglican hialuronato liasa. (Machine-translation by Google Translate, not legally binding)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB640465A GB1060513A (en) 1965-02-15 1965-02-15 Process for the preparation of glucuronoglycosaminoglycan hyaluronate lyase

Publications (1)

Publication Number Publication Date
GB1060513A true GB1060513A (en) 1967-03-01

Family

ID=9813914

Family Applications (1)

Application Number Title Priority Date Filing Date
GB640465A Expired GB1060513A (en) 1965-02-15 1965-02-15 Process for the preparation of glucuronoglycosaminoglycan hyaluronate lyase

Country Status (1)

Country Link
GB (1) GB1060513A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152212A (en) * 1976-02-25 1979-05-01 Biorex Laboratories Limited Process for the purification of glucuronoglycosaminoglycan hyaluronate lyase
FR2495634A1 (en) * 1980-12-08 1982-06-11 Biorex Laboratories Ltd ENZYME NEW AND USEFUL IN THERAPEUTICS
EP0355831A2 (en) * 1988-08-24 1990-02-28 Seikagaku Kogyo Co., Ltd. Purification of glycosaminoglycan degrading enzymes
US6689349B1 (en) 1998-12-23 2004-02-10 Esparma Gmbh Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis
US6719986B1 (en) 1998-12-23 2004-04-13 Esparma Gmbh Hyaluronate lyase used for promoting penetration in topical agents
CN109722424A (en) * 2019-01-25 2019-05-07 山东大学 A method of the separate lactose enzyme from infant faeces

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152212A (en) * 1976-02-25 1979-05-01 Biorex Laboratories Limited Process for the purification of glucuronoglycosaminoglycan hyaluronate lyase
FR2495634A1 (en) * 1980-12-08 1982-06-11 Biorex Laboratories Ltd ENZYME NEW AND USEFUL IN THERAPEUTICS
EP0355831A2 (en) * 1988-08-24 1990-02-28 Seikagaku Kogyo Co., Ltd. Purification of glycosaminoglycan degrading enzymes
EP0355831A3 (en) * 1988-08-24 1991-08-28 Seikagaku Kogyo Co., Ltd. Purification of glycosaminoglycan degrading enzymes
US5198355A (en) * 1988-08-24 1993-03-30 Seikagaku Kogyo Co., Ltd. Purification of glycosaminoglycan degrading enzymes with a sulfated polysaccharide
US6689349B1 (en) 1998-12-23 2004-02-10 Esparma Gmbh Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis
US6719986B1 (en) 1998-12-23 2004-04-13 Esparma Gmbh Hyaluronate lyase used for promoting penetration in topical agents
CN109722424A (en) * 2019-01-25 2019-05-07 山东大学 A method of the separate lactose enzyme from infant faeces
CN109722424B (en) * 2019-01-25 2022-08-05 山东大学 Method for separating lactase from infant excrement

Similar Documents

Publication Publication Date Title
Booyse et al. In vitro incorporation of amino-acids into the contractile protein of human blood platelets
US3396081A (en) Hyaluronic acid preparation and method of producing same
US4314935A (en) Process for recovering interferon
US4184917A (en) Process for producing a structurally modified interferon
US3357894A (en) Proteolytic enzymes of pig pancreas
GB1441751A (en) Purification of albumin by thermocoagulation
GB1356911A (en) Purification and fractionation of carcinoembryonic antigen
UA26847C2 (en) Process for preparing a concentrate of factor vii and von willebrand factor
KR890001581A (en) Tissue Factor Inhibitor
GB1060513A (en) Process for the preparation of glucuronoglycosaminoglycan hyaluronate lyase
US4510084A (en) Method of producing an antithrombin III-heparin concentrate or antithrombin III-heparinoid concentrate
EP0270516A3 (en) Process for the preparation of a fraction containing factor viii (ahf)
Schedl et al. A factor required for the translation of bacteriophage f2 RNA in extracts of T4-infected cells
Nósal et al. Quantitative correlation between degranulation and histamine release following exposure of rat mast cells to compound 48/80 in vitro
US3936351A (en) Method for preparing glucoronyl-glucosamino-glycan sulphates exhibiting antilipasaemic activity
US3597323A (en) Method of purifying l-asparaginase
US3677901A (en) Process for the production of glycerokinase
GB1380056A (en) Process for isolating a fibrin-stabilizing factor
GB1018528A (en) New physiologically active protein fractions from mistletoe and process for their preparation
US3627642A (en) Lysozyme salts
GB1076776A (en) Process for the extraction of elastase
GB842806A (en) Improvements in or relating to the treatment of blood
GB966672A (en) Process for the manufacture of streptokinase
Yamamoto et al. Purification of fish gastric hyaluronidase
SU1247379A1 (en) Method of producing leucocytic alpha-glycoproteid